Thromboembolic Complications in Mild Covid-19 Cases
NCT06695377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 961
Last updated 2024-11-19
Summary
The aim of the study is to investigate the frequency of thromboembolic complications and the factors influencing them in COVID-19 cases that did not require hospitalization. For this purpose, patients registered at two different family health centers in Istanbul were retrospectively screened, and their status regarding post-COVID-19 thromboembolic events was recorded. The sociodemographic characteristics, medical history, COVID-19 treatments received, comorbidities, and current medications of all patients were examined and compared with the occurrence of complications.
Conditions
- COVID 19
- Thromboembolic and Bleeding Complications
- Thromboembolism, Venous
- Post COVID-19
Sponsors & Collaborators
-
Marmara University Pendik Training and Research Hospital
lead OTHER
Principal Investigators
-
Buğu Usanma Koban · Marmara University Medical Faculty
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-09-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Prediction of Thrombosis Using D-dimer Trends in COVID-19
NCT04827160 ·Status: COMPLETED
-
Practice Variation on Antithrombotics in COVID-19
NCT04998799 ·Status: COMPLETED
-
Thromboprophylaxis for Patients in ICU With COVID-19
NCT04623177 ·Status: COMPLETED
-
COVID-19 and Venous Thromboembolism Risk
NCT04569344 ·Status: COMPLETED
-
Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications
NCT05143567 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
NCT04787510 ·Status: COMPLETED
-
Collection of the Thrombo-VaxCov Cohort
NCT04889326 ·Status: WITHDRAWN
-
Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 Infection
NCT06806800 ·Status: COMPLETED
-
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
NCT04535128 ·Status: COMPLETED
-
Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19
NCT04359212 ·Status: COMPLETED
-
Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients
NCT04593654 ·Status: COMPLETED
-
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
NCT04377997 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study
NCT05306821 ·Status: UNKNOWN ·Phase: NA
-
Comparative Study Between Thrombosis Prophylaxis Protocols
NCT00713973 ·Status: COMPLETED
-
Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk
NCT05512923 ·Status: RECRUITING
-
Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
NCT06269302 ·Status: COMPLETED
-
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
NCT04650087 ·Status: COMPLETED ·Phase: PHASE3
-
Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant
NCT05075928 ·Status: UNKNOWN
-
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
NCT06355258 ·Status: RECRUITING ·Phase: PHASE1
-
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
NCT05515549 ·Status: UNKNOWN
-
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
NCT02892565 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Drug-Related Problems in Pulmonary Embolism
NCT06392672 ·Status: COMPLETED ·Phase: NA
-
Incidence and Outcomes of Venous Thromboembolism
NCT00005351 ·Status: COMPLETED
-
Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
NCT05449808 ·Status: UNKNOWN
-
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients
NCT04412304 ·Status: COMPLETED